Ferrer Internacional SA engages in the development, manufacture and commercialization of pharmaceutical products for the diagnosis and treatment of cardiovascular, dermatological, gastrointestinal and respiratory conditions. It also designs and produces active ingredients and nutraceuticals for the food, cosmetics and animal feed industries. The company was founded on April 17, 1940 and is headquartered in Barcelona, Spain.

Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on developing and commercializing therapeutics to treat diseases associated with inflammation, including cardiovascular and autoimmune diseases. Its primary product candidates include varespladib methyl (A-002), which has completed its Phase 2 clinical studies for the treatment of acute coronary syndrome; varespladib sodium (A-001) that is in a Phase 2 clinical study for the prevention of acute chest syndrome associated with sickle cell disease; and A-623, which has completed Phase 1 clinical studies for the treatment of B-cell mediated autoimmune diseases. The company has license agreements with Eli Lilly and Company, and Shionogi & Co., Ltd. to develop and commercialize secretory phospholipase A2 or sPLA2 inhibitors for the treatment of cardiovascular disease and other diseases; and Amgen Inc., to develop and commercialize A-623. Anthera Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Hayward, California.

ACTIVE Health Management, Inc., a subsidiary of CareRx Corp., is a Canadian company located in Toronto, ON. The firm provides healthcare services. It was acquired by CareRx Corp. on June 01, 2009.

Biodesix is a data-driven diagnostic solutions company that provides lung cancer diagnostic testing and biopharma services. The company provides physicians with diagnostic tests for earlier disease detection, more accurate diagnosis, disease monitoring, and better therapeutic guidance, which may lead to improved patient outcomes. Biodesix discovers, develops, and commercializes multivariate protein diagnostics based on its proprietary mass spectrometry-based discovery platform. VeriStrat, a multivariate serum protein test, is Biodesix’s first product developed with this technology. The commercially available test provides oncologists with information to help them select between erlotinib and single-agent chemotherapy for advanced lung cancer patients. Tests are processed in Biodesix’s CLIA-certified laboratory and results are reported in less than 72 hours. In addition to developing novel diagnostics independently, the company also partners with biotechnology and pharmaceutical companies to develop companion diagnostics to improve the utility of therapeutic agents.

Shandong Cancer Hospital is a Chinese private company that operates as a cancer hospital.

3D Biomedicine Science & Technology Co., Ltd. is a private company headquartered in China that manufactures and trades viral RNA auto extraction and purification kits.

Shanghai Jiyuan Biotechnology Co., Ltd., established on 2013-10-29, The scope of business includes engaging in technology development in the professional field of biotechnology,technology transfer,technical consulting,Technical Services,Health Advisory,Electrical Equipment,Mechanical equipment maintenance;Sales of medical devices. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shenzhen Hornetcorn Biotechnology Co., Ltd. principally engages in the research and development of immune cell therapy technology and the provision of immune cell therapy technology to medical institutions. The company was founded on November 29, 2010 and is headquartered in Shenzhen, China.

Guangzhou Shuangyou Biotechnology Co., Ltd., established on 2013-07-18, Business scope includes medical research and experimental development;Biotechnology Development Services;Biotechnology Consulting,communication service;Operation of non-licensed medical devices(i.e. no application required<Medical device operating enterprise license>ready-to-operate medical device",Including Class I medical devices and national regulations do not require application<Medical device operating enterprise license>Ready-to-operate Class II Medical Devices);computer technology development,Technical Services;Wholesale of computer spare parts;Computer Parts Retail;Wholesale of electrical equipment;Instrument wholesale;Wholesale of electronic components;Wholesale of electronic products;Import and export(Excluding franchised products);Technology Import and Export;Auto Parts Wholesale;Machinery Parts Wholesale;Wholesale of communication equipment and supporting equipment;Auto Parts Retail;Communication Equipment Retail;Electronic Components Retail;Electronics retail;Commodity wholesale trade(Except for licensed and approved products);Commodity retail trade(Except for licensed and approved products);

Hangzhou Shengyuan Biotechnology Co., Ltd., established on 2017-06-01, Business scope includes services:Biotechnology,Technical consulting for medical technology,Technical Services,technology development,Achievement transfer,Expo Services;wholesale,retail:Reagent(In addition to drugs,Hazardous chemicals and precursor chemicals),medical instruments(Limited to one category,Class II);Import and export of goods and technology(National law,Except for items prohibited by administrative regulations,law,Projects restricted by administrative regulations can only be operated after obtaining a license);Other legal projects that do not need to be submitted for approval.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Manufactures vaccines for diseases like hepatitis, influenza, rubella and typhoid fever

Wansui Investment Holding (Qingdao) Co., Ltd., established on 2020-10-15, Business scope includes general items:Engage in investment activities with own funds;business management;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Bioblue Technology focuses on the research and development of early tumor diagnosis products such as serum autoantibody profiles of lung cancer. Bioblue Technology's first key product project for early-stage lung cancer non-invasive screening independently adopts the world's leading liquid-phase chip technology, which has important diagnostic value for early screening and diagnosis of lung cancer.

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. Its business scope ranges from scientific, health, agricultural and informatics. The company was founded by Wang Jian on September 9, 1999 and is headquartered in Shenzhen, China.

Changsha Jinliyuan Biotechnology Co., Ltd., established on 2013-04-27, Business scope includes agricultural technology extension services;Primary processing of agricultural products;Agricultural product delivery;Agricultural Machinery Service;Landscaping Engineering Services;flower planting;Flower Rental Service;Natural honey and by-products,bee products(Honey,royal jelly,propolis,Bee pollen,bee products)production;agricultural products,fertilizer,sale of flower crops.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Anhui Deep Blue Medical Technology Co., Ltd., established on 2010-02-04, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of medical masks;Production of protective equipment for medical personnel(Class II medical device);Production of disinfection products for the prevention and control of infectious diseases;Veterinary drug production;pharmaceutical production;Production of hygiene products and single-use medical products;medical service;Drug import and export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Medical Mask Retail;Wholesale medical masks;daily mask(non-medical)Production;daily mask(non-medical)Sales;Production of protective equipment for medical personnel(Ι class medical device);Retailing of protective equipment for healthcare workers;Wholesale of protective equipment for medical staff;Sales of hygiene products and single-use medical products;Production of labor protection products;Technology Import and Export;Medical Research and Experimental Development(Except for licensed business,Can independently operate projects that are not prohibited or restricted by laws and regulations)

Ningbo Aocheng Biotechnology Co., Ltd., established on 2009-02-16, Business scope includes general items:Biochemical product technology research and development;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Class II Medical Device Leasing;Class I Medical Device Leasing;software development;Artificial intelligence application software development;Information Technology Consulting Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Network and Information Security Software Development;Information system operation and maintenance services;Wholesale of computer software, hardware and auxiliary equipment;Medical Research and Experimental Development;Conference and Exhibition Services;Technology Import and Export;Import and export;market survey(Does not include foreign investigations);Bidding agency service;marketing planning;Mechanical Parts,Parts sales;Instrument sales;Machinery sales;electronics sales;Experimental analysis instrument sales;software sales;Office Supplies Sales;Glassware Sales;Sales of plastic products;Sales of technical glass products(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).licensed items:Production of Class II Medical Devices;Class III Medical Device Leasing;Class III medical device business;Production of Class III Medical Devices;food sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).